Cannabinoid Research Studies
Procana is accepting applications to further its own studies in these areas.
What is Kidney Disease?
Kidney disease means that the kidneys are damaged and can't filter blood like they should. This damage can cause wastes to build up in the body. It can also cause other problems that can harm your health. For most people, kidney damage occurs slowly over many years, often due to diabetes or high blood pressure. This is called chronic kidney disease. When someone has a sudden change in kidney function—because of illness, or injury, or have taken certain medications—this is called acute kidney injury.
Procana Medical Studies [Apply]
Procana is accepting applicants to participate in medical studies of controlled dosage CBD for the treatment of Kidney Disease “CBD” Cannabidiol subset studies will be derived from either Cannabis “Marijuana” or Industrial Hemp. Other medical studies may include ratios of “THC” Tetrahydrocannabinol derived from Cannabis, also known as Marijuana to study the treatment for Kidney Disease.
Procana does not warrant, nor does it have approval from the FDA to claim, diagnose or treat any illness or disease with its products containing Hemp, Cannabis or Marijuana with THC or CBD for the treatment of Kidney Disease.
To participate in these ongoing studies, please click here.
Most of the PubMed material consists of abstracts on preclinical research involving single cannabinoid molecules, test tubes, petri dishes, animal experiments, and in some cases human cell-line studies. Although all mammals have cell receptors that respond pharmacologically to cannabinoid compounds, data from animal experiments and other preclinical research is not always applicable to humans.
This data may include articles, surveys, studies or opinions related to THC and CBD from either Marijuana, Cannabis or Hemp in the use of Kidney Disease. This information is for research purposes only, and does not include the use of Procana products.